Yasir Furkan Cagin

Yasir Furkan Cagin

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2016 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
YCYasir Furkan Cagin
Yasir Furkan Cagin
HPHakan Parlakpinar
Hakan Parlakpinar
NVNigar Vardi
Nigar Vardi
APAlaadin Polat
Alaadin Polat
YAYahya Atayan
Yahya Atayan
KTKevser Tanbek
Kevser Tanbek
While the pathogenesis of acetic acid (AA)‑induced colitis is unclear, reactive oxygen species are considered to have a significant effect. The aim of the present study was to elucidate the therapeutic potential of dexpanthenol (Dxp) on the amelioration of colitis in rats. Group I (n=8; control group) was intrarectally administered 1 ml saline solution (0.9%); group II [n=8; AA] was administered 4% AA into the colon via the rectum as a single dose for three consecutive days; group III (n=8; AA + Dxp) was administered AA at the same dosage as group II from day 4, and a single dose of Dxp was administered intraperitoneally; and group IV (n=8; Dxp) was administered Dxp similarly to Group III. Oxidative stress and colonic damage were assessed via biochemical and histologic examination methods. AA treatment led to an increase in oxidative parameters and a decrease in antioxidant systems. Histopathological examination showed that AA treatment caused tissue injury and increased caspase‑3 activity in the distal colon and triggered apoptosis. Dxp treatment caused biochemical and histopathological improvements, indicating that Dxp may have an anti‑oxidant effect in colitis; therefore, Dxp may be a potential therapeutic agent for the amelioration of IBD.

16 May 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
ÖDÖzge Erol Doğan
Özge Erol Doğan
ECEsen Karaca Celik
Esen Karaca Celik
MBMurat Bas
Murat Bas
EAEyüp Hakan Alan
Eyüp Hakan Alan
YCYasir Furkan Cagin
Yasir Furkan Cagin
This study aimed to investigate the effects of the Mediterranean diet (MD), combined with curcumin and resveratrol supplementation, on disease activity, serum inflammatory markers, and quality of life in patients with mild-to-moderate active ulcerative colitis (UC). This study was designed as a prospective multicenter three-arm randomized controlled trial. Participants were randomized to the MD, MD + curcumin, and MD + resveratrol groups. All participants were placed on the MD for 8 weeks. The MD + curcumin group also received 1600 mg/day of curcumin supplementation, whereas the MD + resveratrol group received 500 mg/day of resveratrol supplementation for 8 weeks. Anthropometric measurements, Truelove–Witts Index, Short Form-36, Inflammatory Bowel Disease Questionnaire, Mediterranean Diet Adherence Scale (MEDAS), and laboratory tests were performed at baseline and postintervention. Within-group comparisons showed that MD, MD + curcumin, and MD + resveratrol interventions were effective in reducing disease activity and inflammation and improving quality of life in individuals with UC (p < 0.05). Between-group comparisons revealed no significant difference in all parameters except for the pain subparameter of SF-36 and the MEDAS score (p < 0.05). The MD is an effective and safe intervention to be used in clinical practice in individuals with UC.

1 October 2015 in Archives of Medical Research
Verified
Journal Article
Closed access
YCYasir Furkan Cagin
Yasir Furkan Cagin
MEMehmet Ali Erdogan
Mehmet Ali Erdogan
NSNurhan Sahin
Nurhan Sahin
HPHakan Parlakpinar
Hakan Parlakpinar
YAYahya Atayan
Yahya Atayan
KTKevser Tanbek
Kevser Tanbek

1 October 2016 in Hepatobiliary & Pancreatic Diseases International
Verified
Journal Article
Closed access
YCYasir Furkan Cagin
Yasir Furkan Cagin
YAYahya Atayan
Yahya Atayan
MEMehmet Ali Erdogan
Mehmet Ali Erdogan
FDFirat Dagtekin
Firat Dagtekin
CCCemil Colak
Cemil Colak

14 January 2016 in Free Radical Research
Verified
Journal Article
Closed access
PDF file
YCYasir Furkan Cagin
Yasir Furkan Cagin
YAYahya Atayan
Yahya Atayan
NSNurhan Sahin
Nurhan Sahin
HPHakan Parlakpinar
Hakan Parlakpinar
APAlaadin Polat
Alaadin Polat
AYAzibe Yildiz
Azibe Yildiz
Background and aim It has been reported that intestinal ischemia–reperfusion (I/R) injury results from oxidative stress caused by increased reactive oxygen species. Dexpanthenol (Dxp) is an alcohol analogue with epitelization, anti-inflammatory, antioxidant, and increasing peristalsis activities. In the present study, the aim was to investigate protective and therapeutic effects of Dxp against intestinal I/R injury. Materials and methods Overall, 40 rats were assigned into five groups including one control, one alone Dxp, and three I/R groups (40-min ischemia; followed by 2-h reperfusion). In two I/R groups, Dxp (500 mg/kg, i.m.) was given before or during ischemia. The histopathological findings including apoptotic changes, and also tissue and serum biochemical parameters levels, were determined. Oxidative stress and ileum damage were assessed by biochemical and histological examination. In the control (n = 8) and alone Dxp (n = 8; 500 mg/kg, i.m. of Dxp was given at least 30 min before recording), groups were incised via laparotomy, and electrical activity was recorded from their intestines. In this experiment, the effect of Dxp on the motility of the intestine was examined by analyzing electrical activity. Results In ileum, oxidant levels were found to be higher, while antioxidant levels were found to be lower in I/R groups when compared with controls. Dxp approximated high levels of oxidants than those in the control group, while it increased antioxidant values compared with I/R groups. Histopathological changes caused by intestinal I/R injury and histological improvements were observed in both groups given Dxp. In the Dxp group, electrical signal activity markedly increased compared with the control group. Conclusions Here, it was seen that Dxp had protective and therapeutic effects on intestinal I/R injury and gastrointestinal system peristaltism.

22 February 2019 in Experimental and Therapeutic Medicine
Verified
Journal Article
Closed access
PDF file
YCYasir Furkan Cagin
Yasir Furkan Cagin
YBYilmaz Bilgic
Yilmaz Bilgic
IBİlhami Berber
İlhami Berber
OYOguzhan Yildirim
Oguzhan Yildirim
MEMehmet Ali Erdogan
Mehmet Ali Erdogan
MHMurat Harputluoglu
Murat Harputluoglu
This study was designed to identify and assess risk factors for portal vein thrombosis (PVT) in patients with cirrhosis. A total of 98 cirrhosis patients with PVT were identified and 101 cirrhosis patients without PVT were chosen as the control group in this retrospective study. Several variables were measured and the two groups PVT and non‑PVT were compared statistically. PVT was identified in 98 patients (10%). Significant differences in hematocrit, international normalized ratio, albumin, bilirubin and glucose were determined between the groups (P0.05).